EUVIMEDEUVIMED entdecken
Crossref

Role of 68Ga-FAPI-04 PET/CT in the Initial Staging of Esophageal Cancer

Huipan Liu, Xiao Yang, Zhouxiang You, Zhi Hu, Yue Chen

Nuklearmedizin - NuclearMedicine · 01.02.2023 · 62 (01) · 38-44

DOI: 10.1055/a-1984-8044 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nuklearmedizin - NuclearMedicine, erschienen am 01.02.2023. Verfasst von Huipan Liu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, The Affiliated Hospital of Southwest Medical University, Luzhou, China. Hauptthemen laut MEDLINE: Positron Emission Tomography Computed Tomography, Esophageal Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

To investigate the clinical value of 68Ga-FAPI-04 PET/CT for initial staging of esophageal cancer.

Methods

A total of 44 newly diagnosed patients with esophageal cancer were included in the analysis on the basis of postoperative pathology or clinical and radiologic follow-up.

Results

All primary lesions showed increased 68Ga-FAPI-04 uptake, with an SUVmax of 14.92 ± 6.91. A total of 561 lymph nodes were verified by surgery (507) or clinical and radiologic follow-up (54), of which 92 lymph nodes were diagnosed as showing metastases. Seventy-five lymph nodes with metastases showed positive findings on 68Ga-FAPI-04, with a diameter of about 1.06 ± 0.53 cm and SUVmax of 8.10±4.71. The sensitivity, specificity, accuracy, positive predictive value, and negative predictive value for lymph node metastasis detection were 81.5%, 99.3%, 96.6%, 96.2%, and 96.5%, respectively.

Conclusion

68Ga-FAPI-04 PET/CT showed good diagnostic performance in detecting lymph node metastases of esophageal cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Positron Emission Tomography Computed TomographyEsophageal NeoplasmsHumansRadiopharmaceuticalsFluorodeoxyglucose F18Gallium RadioisotopesQuinolines

Substanzen

RadiopharmaceuticalsFluorodeoxyglucose F18Gallium Radioisotopes68Ga-FAPIQuinolines

Autor:innen und Institutionen

  • Department of Nuclear Medicine, The Affiliated Hospital of Southwest Medical University, Luzhou, China.
  • Nuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province, The Affiliated Hospital of Southwest Medical University, Luzhou, China.
  • Academician (Expert) Workstation of Sichuan Province, The Affiliated Hospital of Southwest Medical University, Luzhou, China.
  • Institute of Nuclear Medicine, Southwest Medical University, Luzhou, China.
  • Department of Nuclear Medicine, The Yibin No. 2 People's Hospital, Yibin, China.
  • Department of Thoracic Surgery, The Affiliated Hospital of Southwest Medical University, Luzhou, China.

Zitieren

APA

Liu, H., Yang, X., You, Z., Hu, Z., & Chen, Y. (2023). Role of 68Ga-FAPI-04 PET/CT in the Initial Staging of Esophageal Cancer. Nuklearmedizin - NuclearMedicine, 62(01), 38-44. https://doi.org/10.1055/a-1984-8044

Vancouver

Liu H, Yang X, You Z, Hu Z, Chen Y. Role of 68Ga-FAPI-04 PET/CT in the Initial Staging of Esophageal Cancer. Nuklearmedizin - NuclearMedicine. 2023;62(01):38-44. doi:10.1055/a-1984-8044

BibTeX
@article{Liu2023,
  author = {Liu, Huipan and Yang, Xiao and You, Zhouxiang and Hu, Zhi and Chen, Yue},
  title = {Role of 68Ga-FAPI-04 PET/CT in the Initial Staging of Esophageal Cancer},
  journal = {Nuklearmedizin - NuclearMedicine},
  year = {2023},
  volume = {62},
  number = {01},
  pages = {38--44},
  doi = {10.1055/a-1984-8044}
}
Kostenlos starten →